111 related articles for article (PubMed ID: 6110278)
1. The tumorigenic and carcinogenic effect of TPA (12-0-tetradecanoylphorbol-13-acetate) when applied to the skin of BALB/cA mice.
Astrup EG; Iversen OH; Elgjo K
Virchows Arch B Cell Pathol Incl Mol Pathol; 1980; 33(3):303-4. PubMed ID: 6110278
[No Abstract] [Full Text] [Related]
2. The carcinogenic effect of TPA (12-0-tetradecanoylphorbol-13-acetate) when applied to the skin of hairless mice.
Iversen UM; Iversen OH
Virchows Arch B Cell Pathol Incl Mol Pathol; 1979 May; 30(1):33-42. PubMed ID: 37642
[TBL] [Abstract][Full Text] [Related]
3. Biological effects of phorbol ester tumor promoters in mouse skin.
Marks F; Fürstenberger G; Ganss M; Seemann D
Prog Clin Biol Res; 1982; 102 pt A():243-59. PubMed ID: 7167438
[No Abstract] [Full Text] [Related]
4. Enhancement of clonal proliferation of mouse mast cells by a tumor-promoting phorbol ester.
Saito H; Sanai Y; Nakamura H; Watanabe N; Ito T; Nagai Y
Cancer Res; 1984 May; 44(5):2110-4. PubMed ID: 6713402
[TBL] [Abstract][Full Text] [Related]
5. Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
Yuspa SH; Ben T; Hennings H; Lichti U
Cancer Res; 1982 Jun; 42(6):2344-9. PubMed ID: 6122503
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of a tumor promoter, 12-O-tetradecanoylphorbol-13-acetate, on induced differentiation of Friend leukemia cells.
Yamasaki H; Saint-Vincent L; Martel N
Cancer Res; 1980 Oct; 40(10):3780-5. PubMed ID: 7438061
[No Abstract] [Full Text] [Related]
7. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of epidermal transglutaminase activity by protease inhibitors.
Kawamura H; Strickland JE; Yuspa SH
Cancer Res; 1983 Sep; 43(9):4073-7. PubMed ID: 6135503
[TBL] [Abstract][Full Text] [Related]
8. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
9. TPA (12-O-tetradecanoyl-phorbol-13-acetate) as a carcinogen for mouse skin. A positive dose-response relationship.
Iversen OH
Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 49(2):129-35. PubMed ID: 2866623
[TBL] [Abstract][Full Text] [Related]
10. Initiator and promoter induced specific changes in epidermal function and biological potential.
Yuspa SH; Hennings H; Lichti U
J Supramol Struct Cell Biochem; 1981; 17(3):245-57. PubMed ID: 7328673
[TBL] [Abstract][Full Text] [Related]
11. The tumourigenic and carcinogenic effect of 12-0-tetradecanoylphorbol-13-acetate when applied to the skin of BALB/cA and hairless (hr/hr) mice.
Astrup EG; Iversen OH
Acta Pathol Microbiol Immunol Scand A; 1983 Mar; 91(2):103-13. PubMed ID: 6846014
[TBL] [Abstract][Full Text] [Related]
12. Diterpene ester-mediated two-stage carcinogenesis.
Goerttler K; Loehrke H; Schweizer J; Hesse B
Carcinog Compr Surv; 1982; 7():75-83. PubMed ID: 6802498
[No Abstract] [Full Text] [Related]
13. Effects of 3-isobutyl-1-methylxanthine and cyclic nucleotides on the biochemical processes linked to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Perchellet JP; Boutwell RK
Cancer Res; 1981 Oct; 41(10):3927-35. PubMed ID: 6169430
[No Abstract] [Full Text] [Related]
14. Biological mechanisms of phorbol myristate acetate-induced inhibition of proadipocyte differentiation.
Yun K; Scott RE
Cancer Res; 1983 Jan; 43(1):88-96. PubMed ID: 6182994
[No Abstract] [Full Text] [Related]
15. Nature of the epidermal hyperplasia produced by mezerein, a weak tumor promoter, in initiated skin of mice.
Argyris TS
Cancer Res; 1983 Apr; 43(4):1768-73. PubMed ID: 6403228
[No Abstract] [Full Text] [Related]
16. Simple phorbol esters as inhibitors of tumor promotion by TPA in mouse skin.
Schmidt R; Hecker E
Carcinog Compr Surv; 1982; 7():57-63. PubMed ID: 7066929
[No Abstract] [Full Text] [Related]
17. Assessment of carcinogenic potential of repeated fish fried oil in mice.
Pandey MK; Das M
Mol Carcinog; 2006 Oct; 45(10):741-51. PubMed ID: 16683249
[TBL] [Abstract][Full Text] [Related]
18. Morphological & biochemical studies on separated constituents of mouse skin treated with phorbol myristate acetate.
Bhisey RA; Bhide SV; Sirsat SM
Indian J Exp Biol; 1979 Jan; 17(1):15-8. PubMed ID: 468315
[No Abstract] [Full Text] [Related]
19. The time needed for normalization of hairless mouse epidermis after treatment with twice weekly topical skin applications of 10 nmol 12-O-tetradecanoylphorbol-13-acetate in acetone, or acetone alone, for 18 weeks. A morphologic and cell kinetic study.
Iversen OH; Paulsen JE; Schjølberg A
Carcinogenesis; 1981; 2(12):1353-8. PubMed ID: 7326834
[No Abstract] [Full Text] [Related]
20. Suppression of the cytotoxic response of mouse lymphocytes to syngeneic tumor cells by tumor-promoting phorbol ester.
Fredrickson GG; Bennett M
Cancer Res; 1982 Sep; 42(9):3601-6. PubMed ID: 7105034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
